Abstract

It is unclear whether the conceptual coverages of the instruments available to evaluate the health-related quality of life (HRQoL) of multiple myeloma (MM) patients are adequate in the relapsed or refractory (R/R) setting, with respect to the FDA’s patient-reported outcome (PRO) guidance. To address this uncertainty, we conducted qualitative interviews with R/R MM patients and compared the results to the conceptual frameworks of three existing instruments. Two consecutive sets (n=15 and n=8) of qualitative concept elicitation (CE) interviews were conducted with R/R MM patients in the U.S. The concepts reported were compared with the conceptual frameworks of the EORTC QLQ-C30 and QLQ-MY20, FACT-MM, and MDASI-MM. In addition, a conceptual model was devised based on the results of these interviews, and an analysis of the relative timing (with respect to treatment/disease course) of the reported symptoms and impacts was conducted. A total of 23 R/R MM patients (age range=50 to 89 years; mean age=66.7±10.1 years; male=56.5%) participated in the CE interviews. A total of 37 symptom concepts and 55 HRQoL impacts were reported. Of the six symptom concepts reported by >2 patients, five (83.3%) were covered by the QLQ-C30 and MY-20, three (50.0%) by the FACT-MM, and three (50.0%) by the MDASI-MM. Of the 23 impacts reported by >2 patients, 14 (60.9%) were covered by the QLQ-C30 and MY-20, 9 (39.1%) by the FACT-MM, and 7 (30.4%) by the MDASI-MM. Analysis of the timing of symptom/impact reporting revealed that the majority of concepts noted by >2 MM patients were present both pre- and post-relapse. These findings indicate that the EORTC QLQ-C30 and QLQ-MY20 instruments are appropriate for capturing the symptom and impact domains most often reported by R/R MM patients, although room may remain for improvement in assessing functional impacts at the conceptual level in this population.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.